Exome Asset Management »

Mbx Biosciences shares owned by Exome Asset Management

Quarter-by-quarter ownership of Mbx Biosciences shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $525k 30k 17.50

More positions owned by Exome Asset Management

Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
Guardant Health (GH)
Eli Lilly & Co. (LLY)
I Mab Sponsored Ads (IMAB)
Praxis Precision Medicines I Com New (PRAX)
Vera Therapeutics Cl A (VERA)
Astrazeneca Sponsored Adr (AZN)
Disc Medicine (IRON)
89bio (ETNB)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Tenet Healthcare Corp Com New (THC)

View all positions for Exome Asset Management

Top funds holding Mbx Biosciences

Group One Trading
Exome Asset Management
Simplex Trading

View all funds holding Mbx Biosciences